Wespac Advisors So Cal, LLC Vertex Pharmaceuticals Inc Transaction History

Wespac Advisors So Cal, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$181.39 - $202.99 $1.45 Million - $1.62 Million	-7,975 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $878,390 - $1.04 Million	4,685 Added 142.4%	7,975 $1.61 Million
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $62,106 - $72,393	300 Added 10.03%	3,290 $707,000
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $618,959 - $825,509	2,990 New	2,990 $707,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.